FCS Announcement

We are collecting anonymised information on patients with familial chylomicronaemia syndrome (FCS)/multifactorial chylomicronaemia syndrome (MCS) as a service evaluation & quality improvement project. The project aims to improve understanding of natural history of FCS and to validate the use of FCS scoring algorithm. The project is approved by Manchester University …

Continue reading


Re-scheduled September 3-4, 2020 15th LIPID CLUB AND THERAPEUTIC APHERESIS 1st JOINT MEETING WITH THE NATIONAL ASSOCIATION FOR FAMILIAL HYPERCHOLESTEROLAEMIA (A.N.I.F. Italia) TWENTY YEARS CELEBRATION Advanced Course on Clinical Lipidology, Metabolicdisorders, and atherosclerosis preventionFocus on novel drugs and therapeutic apheresis Rome, September 3-4, 2020Globus HotelViale Ippocrate, 119 – 00161 RomeParagrafo …

Continue reading


Familial Chylomicronaemia Syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS) register announcement. See in details: FCS MCS register call-to-participate

E-ISFA 2020 Announcement

3rd Congress of the European Group – International Society for Apheresis (E-ISFA) Dresden, March 19 to 21, 2020   Congress Topics Recent progress in lipoprotein apheresis Homozygous familial hypercholesterolemia Lipoprotein(a) Competition with drugs Plasma exchange Immunoadsorption – indications, results, future perspectives Experience with extracorporeal therapy in children and during pregnancy Apheresis …

Continue reading